Drug Shortage Report for TEVA-TRIACOMB
Report ID | 153153 |
Drug Identification Number | 00550507 |
Brand name | TEVA-TRIACOMB |
Common or Proper name | TRIACOMB CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GRAMICIDIN NEOMYCIN NYSTATIN TRIAMCINOLONE ACETONIDE |
Strength(s) | 0.25MG 2.5MG 100000UNIT 1MG |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 30G |
ATC code | D07CB |
ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-19 |
Estimated end date | 2023-07-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v26 | 2023-04-27 | French | Compare |
v25 | 2023-04-27 | English | Compare |
v24 | 2023-02-02 | French | Compare |
v23 | 2023-02-02 | English | Compare |
v22 | 2022-12-01 | French | Compare |
v21 | 2022-12-01 | English | Compare |
v20 | 2022-12-01 | French | Compare |
v19 | 2022-12-01 | English | Compare |
v18 | 2022-12-01 | French | Compare |
v17 | 2022-12-01 | English | Compare |
v16 | 2022-08-18 | French | Compare |
v15 | 2022-08-18 | English | Compare |
v14 | 2022-06-30 | French | Compare |
v13 | 2022-06-30 | English | Compare |
v12 | 2022-06-16 | French | Compare |
v11 | 2022-06-16 | English | Compare |
v10 | 2022-06-03 | French | Compare |
v9 | 2022-06-03 | English | Compare |
v8 | 2022-04-21 | French | Compare |
v7 | 2022-04-21 | English | Compare |